Trial Profile
Single Center, Placebo Controlled, Double-Blind Study to the Treatment of HPV Infected Cervix With AV2 Antiviral Spray and Assessment of Viral Load
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs AV2 DM (Primary)
- Indications Human papillomavirus infections
- Focus Therapeutic Use
- 08 Nov 2012 Planned End Date changed from 1 Dec 2013 to 1 Jan 2013 as reported by ClinicalTrials.gov.
- 08 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 17 Sep 2012 Planned End Date changed from 1 Mar 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.